These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 23375794)

  • 1. Synthesis and structure-activity relationship analysis of caffeic acid amides as selective matrix metalloproteinase inhibitors.
    Shi ZH; Li NG; Shi QP; Tang H; Tang YP; Li W; Yin L; Yang JP; Duan JA
    Bioorg Med Chem Lett; 2013 Mar; 23(5):1206-11. PubMed ID: 23375794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, synthesis and biological evaluation of ferulic Acid amides as selective matrix metalloproteinase inhibitors.
    Shi ZH; Li NG; Shi QP; Tang H; Tang YP; Li W; Yin L; Yang JP; Duan JA
    Med Chem; 2013 Nov; 9(7):947-54. PubMed ID: 23061601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis, structure and structure-activity relationship analysis of caffeic acid amides as potential antimicrobials.
    Fu J; Cheng K; Zhang ZM; Fang RQ; Zhu HL
    Eur J Med Chem; 2010 Jun; 45(6):2638-43. PubMed ID: 20181415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phosphoramidate-based peptidomimetic inhibitors of membrane type-1 matrix metalloproteinase.
    Mendes DE; Wong-On-Wing A; Berkman CE
    J Enzyme Inhib Med Chem; 2016; 31(1):167-71. PubMed ID: 25815671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis of derivatives of methyl rosmarinate and their inhibitory activities against matrix metalloproteinase-1 (MMP-1).
    Yuan H; Lu W; Wang L; Shan L; Li H; Huang J; Sun Q; Zhang W
    Eur J Med Chem; 2013 Apr; 62():148-57. PubMed ID: 23353736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel and therapeutic effect of caffeic acid and caffeic acid phenyl ester on hepatocarcinoma cells: complete regression of hepatoma growth and metastasis by dual mechanism.
    Chung TW; Moon SK; Chang YC; Ko JH; Lee YC; Cho G; Kim SH; Kim JG; Kim CH
    FASEB J; 2004 Nov; 18(14):1670-81. PubMed ID: 15522912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Caffeic acid phenyl ester in propolis is a strong inhibitor of matrix metalloproteinase-9 and invasion inhibitor: isolation and identification.
    Jin UH; Chung TW; Kang SK; Suh SJ; Kim JK; Chung KH; Gu YH; Suzuki I; Kim CH
    Clin Chim Acta; 2005 Dec; 362(1-2):57-64. PubMed ID: 16004979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Battle tactics against MMP-9; discovery of novel non-hydroxamate MMP-9 inhibitors endowed with PI3K/AKT signaling attenuation and caspase 3/7 activation via Ugi bis-amide synthesis.
    Ayoup MS; Fouad MA; Abdel-Hamid H; Ramadan ES; Abu-Serie MM; Noby A; Teleb M
    Eur J Med Chem; 2020 Jan; 186():111875. PubMed ID: 31740054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of caffeic acid amide analogues as anti-platelet aggregation and anti-oxidative agents.
    Hung CC; Tsai WJ; Kuo LM; Kuo YH
    Bioorg Med Chem; 2005 Mar; 13(5):1791-7. PubMed ID: 15698796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, synthesis and preliminary evaluation of α-sulfonyl γ-(glycinyl-amino)proline peptidomimetics as matrix metalloproteinase inhibitors.
    Zhang J; Li X; Jiang Y; Feng J; Li X; Zhang Y; Xu W
    Bioorg Med Chem; 2014 Jun; 22(11):3055-64. PubMed ID: 24755524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MMP-13 selective alpha-sulfone hydroxamates: identification of selective P1' amides.
    Fobian YM; Freskos JN; Barta TE; Bedell LJ; Heintz R; Kassab DJ; Kiefer JR; Mischke BV; Molyneaux JM; Mullins P; Munie GE; Becker DP
    Bioorg Med Chem Lett; 2011 May; 21(10):2823-5. PubMed ID: 21493063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progress towards water-soluble triazole-based selective MMP-2 inhibitors.
    Fabre B; Filipiak K; Zapico JM; Díaz N; Carbajo RJ; Schott AK; Martínez-Alcázar MP; Suárez D; Pineda-Lucena A; Ramos A; de Pascual-Teresa B
    Org Biomol Chem; 2013 Oct; 11(38):6623-41. PubMed ID: 23989288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and 5-lipoxygenase inhibitory activity of new cinnamoyl and caffeoyl clusters.
    Doiron J; Boudreau LH; Picot N; Villebonet B; Surette ME; Touaibia M
    Bioorg Med Chem Lett; 2009 Feb; 19(4):1118-21. PubMed ID: 19152786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sulfonyl phosphonic 1,4-dithia-7-azaspiro[4,4]nonane derivatives as matrix metalloproteinase inhibitors: Synthesis, a docking study, and biological evaluation.
    Zhang H; Li X; Wang X; Xu W; Zhang J
    Drug Discov Ther; 2017; 11(3):118-125. PubMed ID: 28757512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and evaluation of caffeic acid amides as antioxidants.
    Rajan P; Vedernikova I; Cos P; Berghe DV; Augustyns K; Haemers A
    Bioorg Med Chem Lett; 2001 Jan; 11(2):215-7. PubMed ID: 11206462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, synthesis, and biological activity of novel, potent, and highly selective fused pyrimidine-2-carboxamide-4-one-based matrix metalloproteinase (MMP)-13 zinc-binding inhibitors.
    Nara H; Sato K; Kaieda A; Oki H; Kuno H; Santou T; Kanzaki N; Terauchi J; Uchikawa O; Kori M
    Bioorg Med Chem; 2016 Dec; 24(23):6149-6165. PubMed ID: 27825552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, synthesis and evaluation of novel metalloproteinase inhibitors based on L-tyrosine scaffold.
    Cheng XC; Wang RL; Dong ZK; Li J; Li YY; Li RR
    Bioorg Med Chem; 2012 Oct; 20(19):5738-44. PubMed ID: 22967811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery of novel, highly potent, and selective quinazoline-2-carboxamide-based matrix metalloproteinase (MMP)-13 inhibitors without a zinc binding group using a structure-based design approach.
    Nara H; Sato K; Naito T; Mototani H; Oki H; Yamamoto Y; Kuno H; Santou T; Kanzaki N; Terauchi J; Uchikawa O; Kori M
    J Med Chem; 2014 Nov; 57(21):8886-902. PubMed ID: 25264600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, synthesis, and evaluation of caffeic acid amides as synergists to sensitize fluconazole-resistant Candida albicans to fluconazole.
    Dai L; Zang C; Tian S; Liu W; Tan S; Cai Z; Ni T; An M; Li R; Gao Y; Zhang D; Jiang Y
    Bioorg Med Chem Lett; 2015 Jan; 25(1):34-7. PubMed ID: 25466190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design and synthesis of novel imidazole-substituted dipeptide amides as potent and selective inhibitors of Candida albicans myristoylCoA:protein N-myristoyltransferase and identification of related tripeptide inhibitors with mechanism-based antifungal activity.
    Devadas B; Freeman SK; Zupec ME; Lu HF; Nagarajan SR; Kishore NS; Lodge JK; Kuneman DW; McWherter CA; Vinjamoori DV; Getman DP; Gordon JI; Sikorski JA
    J Med Chem; 1997 Aug; 40(16):2609-25. PubMed ID: 9258368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.